MYMD PHARMACEUTICALS INC
COM · CUSIP 62856X102
1
institutional holders
-50 vs Q4 2023
18
shares reported held*
$43reported value*
0 new
0 added
1 reduced
49 sold out
net sold ≈ $15.1m (-6.3m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.39.
Trends to Q1 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 44 |
| Q4 2022 | 44 |
| Q1 2023 | 50 |
| Q2 2023 | 48 |
| Q3 2023 | 51 |
| Q4 2023 | 51 |
| Q1 2024 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 19 | 16 |
| Q1 2023 | 24 | 12 |
| Q2 2023 | 18 | 13 |
| Q3 2023 | 23 | 20 |
| Q4 2023 | 17 | 17 |
| Q1 2024 | 0 | 50 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q2 2023 | $191.4k | $323.3k | 1.69 |
| Q3 2023 | $35.1k | $120.3k | 3.43 |
| Q4 2023 | $11.1k | $16.8k | 1.52 |
| Q1 2024 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| Mirae Asset Global Investments Co., Ltd. | Sold out | -3.1m |
| VANGUARD GROUP INC | Sold out | -1.5m |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -291.2k |
| BlackRock Inc. | Sold out | -206.1k |
| Praetorian Wealth Management, Inc. | Sold out | -200.0k |
| Cambria Investment Management, L.P. | Sold out | -171.6k |
| STATE STREET CORP | Sold out | -120.3k |
| NWAM LLC | Sold out | -68.0k |
| MILLENNIUM MANAGEMENT LLC | Sold out | -62.1k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Sold out | -60.3k |
Holders, Q1 2024
| Manager | Shares | Change |
|---|---|---|
| St. Johns Investment Management Company, LLC 0.00% of their portfolio | 18 $43 | Reduced -476 |